مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Verion

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

video

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

sound

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Version

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

View:

1,393
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Download:

0
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Cites:

Information Journal Paper

Title

EFFECTIVENESS AND ACTING PERIOD OF SANDOSTATIN LAR IN THE TREATMENT OF ACROMEGALY

Author(s)

HASHEMIPOOR S. | ARDESHIR LARIJANI MOHAMMAD BAGHER | BARADAR JALILI R. | MOHAJERI MR. | Issue Writer Certificate 

Pages

  31-36

Abstract

 Background: Pharmacotherapy of ACROMEGALY has been successful in recent years. The therapeutic efficacy of long-acting sandostatin in the treatment of ACROMEGALY has been established in multiple studies. In this report, we investigated the effectiveness of multiple injections of sandostatin and its acting period in Tehran in 2001. Materials and Methods: In this Quasi-experimental study five diagnosed patients with ACROMEGALY after hypophysectomy were treated with SANDOSTATIN LAR and followed up for at least 63 days after injection. After octreotide test, a dose of 30 mg sandostatin was prescribed for 3 injections. Frequency of mean daily growth hormons (GH) less than 5µg/L were compared after the first and the third injections. Then acting time of the drug was assessed. The efficacy of 30 and 40 mg doses were compared in 3 cases. Results: There was no relationship between response rate to octreotide and sandostatin. Frequency of GH<5µg/L after the third injection was higher than that of the first one (P<0.01). Therapeutic effect of the drug continued for 42 days after the treatment in responding patients. Conclusion: Octreotide test (with single dose injection) is not a good method for prediction of patients' response to treatment. Measuring GH after multiple injections is a better method for this purpose. Drug injection interval should be determined separately for each patient.

Cites

  • No record.
  • References

  • No record.
  • Cite

    APA: Copy

    HASHEMIPOOR, S., ARDESHIR LARIJANI, MOHAMMAD BAGHER, BARADAR JALILI, R., & MOHAJERI, MR.. (2003). EFFECTIVENESS AND ACTING PERIOD OF SANDOSTATIN LAR IN THE TREATMENT OF ACROMEGALY. JOURNAL OF ADVANCES IN MEDICAL AND BIOMEDICAL RESEARCH, 11(43), 31-36. SID. https://sid.ir/paper/61118/en

    Vancouver: Copy

    HASHEMIPOOR S., ARDESHIR LARIJANI MOHAMMAD BAGHER, BARADAR JALILI R., MOHAJERI MR.. EFFECTIVENESS AND ACTING PERIOD OF SANDOSTATIN LAR IN THE TREATMENT OF ACROMEGALY. JOURNAL OF ADVANCES IN MEDICAL AND BIOMEDICAL RESEARCH[Internet]. 2003;11(43):31-36. Available from: https://sid.ir/paper/61118/en

    IEEE: Copy

    S. HASHEMIPOOR, MOHAMMAD BAGHER ARDESHIR LARIJANI, R. BARADAR JALILI, and MR. MOHAJERI, “EFFECTIVENESS AND ACTING PERIOD OF SANDOSTATIN LAR IN THE TREATMENT OF ACROMEGALY,” JOURNAL OF ADVANCES IN MEDICAL AND BIOMEDICAL RESEARCH, vol. 11, no. 43, pp. 31–36, 2003, [Online]. Available: https://sid.ir/paper/61118/en

    Related Journal Papers

    Related Seminar Papers

  • No record.
  • Related Plans

  • No record.
  • Recommended Workshops






    Move to top
    telegram sharing button
    whatsapp sharing button
    linkedin sharing button
    twitter sharing button
    email sharing button
    email sharing button
    email sharing button
    sharethis sharing button